{"slideshow_credits": null, "snippet": "Statins are the popular choice for lowering cholesterol, but could result in a sharp increase in the incidence of Type 2 diabetes.", "abstract": null, "section_name": "Opinion", "print_page": "", "document_type": "article", "byline": {"person": [{"lastname": "TOPOL", "rank": 1, "firstname": "Eric", "role": "reported", "organization": "", "middlename": "J."}], "original": "By ERIC J. TOPOL", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/03/05/opinion/the-diabetes-dilemma-for-statin-users.html", "lead_paragraph": "Statins are the popular choice for lowering cholesterol, but could result in a sharp increase in the incidence of Type 2 diabetes.", "headline": {"main": "The Diabetes Dilemma for Statin Users", "print_headline": "The Diabetes Dilemma for Statin Users", "content_kicker": "Op-Ed Contributor", "kicker": "Op-Ed Contributor"}, "_id": "53f437ff38f0d857ea2d0d52", "word_count": "739", "multimedia": [], "pub_date": "2012-03-05T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"value": "Statins (Cholesterol-Lowering Drugs)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Diabetes", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Cholesterol", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Crestor (Drug)", "name": "subject", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}